Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo.
暂无分享,去创建一个
J. Cohn | J. S. Janicki | K. Weber | T. Levine | G. Kinasewitz | J. Franciosa | M. Henis | J. West | J. S. Janicki | K. T. Weber | J. N. Cohn | T. B. Levine | Gary T. Kinasewitz | James W. West | Marc Henis
[1] A. Fishman,et al. Vasodilator and inotropic agents in treatment of chronic cardiac failure: clinical experience and response in exercise performance. , 1981, American heart journal.
[2] J S Janicki,et al. Contractile mechanics and interaction of the right and left ventricles. , 1981, The American journal of cardiology.
[3] B. Massie,et al. Long‐term Vasodilator Therapy for Heart Failure: Clinical Response and its Relationship to Hemodynamic Measurements , 1981, Circulation.
[4] T. Levine,et al. Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. , 1981, The American journal of cardiology.
[5] J. Cohn,et al. Contrasting immediate and long-term effects of isosorbide dinitrate on exercise capacity in congestive heart failure. , 1980, The American journal of medicine.
[6] N. Reichek,et al. Long-term vasodilator therapy with trimazosin in chronic cardiac failure. , 1980, The New England journal of medicine.
[7] R. Gorlin,et al. Importance of left ventricular chamber size in determining the response to hydralazine in severe chronic heart failure. , 1980, The New England journal of medicine.
[8] B. Brundage,et al. Oral hydralazine in chronic heart failure: sustained beneficial hemodynamic effects. , 1980, Annals of internal medicine.
[9] R. Gorlin,et al. Dose requirements of hydralazine in patients with severe chronic congestive heart failure. , 1980, The American journal of cardiology.
[10] R. Gorlin,et al. Hemodynamic evaluation of hydralazine dosage in refractory heart failure , 1980, Clinical pharmacology and therapeutics.
[11] J. Cohn,et al. Sustained hemodynamic effects without tolerance during long-term isosorbide dinitrate treatment of chronic left ventricular failure. , 1980, The American journal of cardiology.
[12] W. Parmley,et al. Metabolic Assessment of Exercise in Chronic Heart Failure Patients: Treated with Short–term Vasodilators , 1980, Circulation.
[13] E. Braunwald,et al. Long-term therapy of heart failure with prazosin: a randomized double blind trial. , 1980, The American journal of cardiology.
[14] R. Peter,et al. Oral hydralazine therapy for primary pulmonary hypertension. , 1980, The New England journal of medicine.
[15] J. P. Gilmore,et al. Changes in the sensitivity of left atrial receptors following reversal of heart failure. , 1979, The American journal of physiology.
[16] B. Brundage,et al. Influence of short-term oral hydralazine therapy on exercise hemodynamics in patients with severe chronic heart failure. , 1979, The American journal of cardiology.
[17] M. Wilén,et al. Functional capacity of patients with chronic left ventricular failure. Relationship of bicycle exercise performance to clinical and hemodynamic characterization. , 1979, The American journal of medicine.
[18] D. Fitchett,et al. Hydralazine in the management of left ventricular failure. , 1979, The American journal of cardiology.
[19] P. Rocha,et al. Regional Left Ventricular Function Assessed by Contrast Angiography in Acute Myocardial Infarction , 1979, Circulation.
[20] W. Aronow,et al. Effect of Prazosin vs Placebo on Chronic Left Ventricular Heart Failure , 1979, Circulation.
[21] J. Cohn,et al. Contrasting acute and chronic effects of nitrates on exercise capacity in heart failure , 1979 .
[22] J. Cohn,et al. Nitrate Therapy for Congestive Heart Failure , 1978 .
[23] W. Aronow,et al. Effect of the vasodilator trimazosin versus placebo on exercise performance in chronic left ventricular failure. , 1977, The American journal of cardiology.
[24] J. Cohn,et al. Hemodynamic improvement after oral hydralazine in left ventricular failure: a comparison with nitroprusside infusion in 16 patients. , 1977, Annals of internal medicine.
[25] B. Massie,et al. Oral Hydralazine Therapy for Chronic Refractory Heart Failure , 1976, Circulation.
[26] J. Cohn,et al. Hemodynamic Effects of Orally Administered Isosorbide Dinitrate in Patients with Congestive Heart Failure , 1974, Circulation.
[27] R A Bruce,et al. Methods of exercise testing. Step test, bicycle, treadmill, isometrics. , 1974, The American journal of cardiology.
[28] J. Forrester,et al. Pulmonary vascular congestion in acute myocardial infarction: hemodynamic and radiologic correlations. , 1972, Annals of internal medicine.
[29] H. Spotnitz,et al. Effects of Chronic Right Ventricular Volume and Pressure Loading on Left Ventricular Performance , 1971, Circulation.
[30] T. W. Moir,et al. Effect of Left Ventricular Hypertension, Ischemia and Vasoactive Drugs on the Myocardial Distribution of Coronary Flow , 1967, Circulation research.
[31] J. Ross,et al. Left Ventricular Performance During Muscular Exercise in Patients with and without Cardiac Dysfunction , 1966, Circulation.
[32] D. Moore-Jones,et al. Radioautographic Localization of Hydralazine-1-C14 in Arterial Walls.∗ , 1966, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.